News

Andy Skibo Of MedImmune/AstraZeneca Will Be A Featured Panelist For Outsourced Pharma West Conference

Request Information
AndrewSkibo

The Outsourced Pharma West Conference and Exhibition yesterday announced that Andy Skibo will be a featured panelist for the conference program. Mr. Skibo is EVP Operations for MedImmune, as well as RVP Supply Biologics for AstraZeneca. He joins a collective of industry executives participating in the conference, representing Merck, Shire, Pfizer, and others.

Outsourced Pharma West will be held November 10-11 in San Francisco and is co-produced by BayBio, Northern California’s life science association, and Life Science Leader, a publication with a worldwide readership of 51,000 in the biopharma and pharma industries. The educational focus of the conference is best business practices impacting the outsourcing of pharmaceutical development and manufacturing. The program will be attended by leadership from emerging through big pharma and biopharma companies.

Mr. Skibo currently leads biological manufacturing operations across seven sites, with responsibilities for all AstraZeneca engineering projects worldwide. Previously, he supervised construction of an award-winning MedImmune antibody-manufacturing facility in Maryland and oversaw large-scale capital projects at all MedImmune facilities. Earlier in his career, Mr. Skibo held positions of leadership with Amgen, Genentech, Foster Wheeler Corp, and Monsanto, among others, with experience in manufacturing, engineering, commercialization and development.

“When you consider that Skibo has nearly 40 year experience in the area of pharma/biologic manufacturing, it seemed a natural to invite him to share his wisdom,” says Rob Wright, chief editor of Life Science Leader magazine. Conference session topics at Outsourced Pharma West include outsourcing relationship models, building an internal outsourcing infrastructure, and effective scaling strategies.

Mr. Skibo appeared on the cover of Life Science Leader magazine in May. His feature article addressed a risk-based approach to modeling and planning for biologics manufacturing capacity. In a recent conversation, Mr. Skibo shared with Wright one of his biggest concerns — getting the manufacturing equation correct when it comes to balancing cost versus quality, while managing risk around the supply chain. “We are thrilled to have him as part of the OPW faculty,” Wright says.

Outsourced Pharma West is co-produced by BayBio, Life Science Leader, and OutsourcedPharma.com, with support from the Life Science Training Institute and Rondaxe.

For more information on Outsourced Pharma West, visit www.outsourcedpharmawest.com. Inquiries can be sent directly to info@outsourcedpharmawest.com or 814-897-7700 x 174.

About BayBio

BayBio, Northern California’s life science association, supports the regional bioscience community with programs in advocacy, enterprise support, and research collaboration. BayBio’s membership of over 500 companies ranges from start-ups to research institutions and life sciences investors. The affiliated BayBio Institute fosters entrepreneurship, science education, and life science career development.

About Life Science Leader

The vision of Life Science Leader magazine is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute.

Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.